Share Price and Basic Stock Data
Last Updated: December 11, 2025, 10:57 pm
| PEG Ratio | 0.12 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Murae Organisor Ltd operates in the pharmaceuticals sector, a field known for its volatility and rapid shifts in demand. The company’s reported sales have shown a tumultuous trajectory over recent quarters, with significant fluctuations. For instance, sales dropped from ₹7.11 Cr in September 2022 to just ₹0.43 Cr by September 2023, before an astonishing leap to ₹58.01 Cr in September 2024. This rollercoaster ride raises questions about the underlying factors driving these changes. The drastic variations may stem from product launches, regulatory approvals, or shifts in market demand, highlighting both the potential and unpredictability of the pharmaceutical industry. Overall, Murae’s revenue performance indicates a company in transition, with the latest figures suggesting a potential for recovery or growth, contingent on strategic management and market conditions.
Profitability and Efficiency Metrics
When assessing Murae Organisor’s profitability, the numbers present a mixed picture. The company recorded an operating profit margin (OPM) of just 0.75%, which is notably low compared to industry standards. Over the past year, the OPM has fluctuated wildly, peaking at 151.16% in March 2024 but often dipping into negative territory. Net profits have also been inconsistent, with a reported ₹15 lakh for the most recent fiscal year. Such volatility raises concerns about operational efficiency and cost management. On the flip side, the interest coverage ratio (ICR) stands at a comfortable 3.63x, indicating that the company can meet its interest obligations without undue stress. However, the risk of operational inefficiencies remains a significant hurdle, suggesting that while Murae may have potential, it needs to stabilize its profitability metrics to attract long-term investor confidence.
Balance Sheet Strength and Financial Ratios
Murae Organisor’s balance sheet reveals a complex financial position. With total borrowings reported at ₹213 Cr against reserves of ₹23 Cr, the company’s leverage appears elevated. The debt-to-equity ratio is concerning, indicating the company is heavily reliant on borrowed funds to fuel its operations. This reliance can be risky, especially in a sector that requires constant innovation and investment. The cash conversion cycle (CCC) is another area of concern, standing at 24 days, which seems manageable but has shown a significant increase in previous years, suggesting potential liquidity issues. The price-to-book value ratio (P/BV) at 2.02x indicates that the stock may be overvalued relative to its book value, which could deter value-focused investors. Collectively, these factors point to a balance sheet that requires careful navigation to ensure long-term sustainability.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Murae Organisor Ltd shows a robust public presence, with public shareholders comprising 99.99% of the total ownership as of December 2023. This high percentage of public ownership indicates a broad base of retail investors, which can be a double-edged sword. While it signifies confidence among retail investors, the absence of institutional backing, such as from foreign institutional investors (FIIs) or domestic institutional investors (DIIs), could limit the stock’s growth potential. The number of shareholders has steadily increased, reaching 1,33,664, suggesting growing interest in the company despite its financial challenges. However, the lack of promoter or institutional stakes raises concerns about the strategic direction and long-term vision for the company, potentially leaving it vulnerable to market fluctuations and investor sentiment.
Outlook, Risks, and Final Insight
Looking ahead, Murae Organisor Ltd faces a mixed outlook fraught with both opportunities and risks. The pharmaceutical sector is ripe with potential, especially for companies that can innovate and adapt quickly to market demands. However, Murae’s erratic revenue streams and operational inefficiencies present significant challenges. Investors should be cautious, as the company’s heavy reliance on debt could amplify risks, especially if cash flows do not stabilize. Furthermore, the absence of institutional support may limit the stock’s ability to weather market downturns. Overall, while Murae Organisor has the potential for growth, particularly if it can harness its recent sales surge, investors must remain vigilant about the inherent risks associated with its financial structure and operational performance. In this volatile landscape, a discerning approach will be essential for those looking to engage with this stock.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Lactose (India) Ltd | 145 Cr. | 115 | 237/84.3 | 32.1 | 49.6 | 0.00 % | 12.9 % | 9.69 % | 10.0 |
| MPS Pharmaa Ltd | 3.38 Cr. | 1.77 | 4.33/1.76 | 0.33 | 0.00 % | 9.79 % | 59.0 % | 10.0 | |
| Gujarat Themis Biosyn Ltd | 4,234 Cr. | 391 | 479/192 | 87.7 | 24.3 | 0.17 % | 27.3 % | 21.7 % | 1.00 |
| Gujarat Terce Laboratories Ltd | 32.3 Cr. | 43.5 | 92.2/37.2 | 10.6 | 0.00 % | 41.4 % | 14.6 % | 10.0 | |
| Gujarat Inject (Kerala) Ltd | 45.4 Cr. | 31.0 | 31.0/17.0 | 108 | 6.93 | 0.00 % | 13.5 % | 11.0 % | 10.0 |
| Industry Average | 20,419.39 Cr | 1,154.58 | 52.81 | 202.18 | 0.35% | 16.29% | 15.20% | 6.10 |
Quarterly Result
| Metric | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 4.74 | 4.28 | 7.11 | 1.17 | 1.53 | 1.71 | 0.43 | 0.40 | 0.86 | 0.23 | 58.01 | 281.05 | 515.53 |
| Expenses | 10.02 | 4.76 | 7.05 | 1.04 | 0.32 | 2.37 | 1.38 | 0.34 | -0.44 | 0.47 | 56.88 | 275.79 | 511.64 |
| Operating Profit | -5.28 | -0.48 | 0.06 | 0.13 | 1.21 | -0.66 | -0.95 | 0.06 | 1.30 | -0.24 | 1.13 | 5.26 | 3.89 |
| OPM % | -111.39% | -11.21% | 0.84% | 11.11% | 79.08% | -38.60% | -220.93% | 15.00% | 151.16% | -104.35% | 1.95% | 1.87% | 0.75% |
| Other Income | 5.42 | 0.87 | 0.00 | 1.40 | 0.00 | 0.66 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest | 0.00 | 0.00 | 0.00 | 0.14 | 0.15 | 0.26 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation | 0.00 | 0.02 | 0.02 | 0.03 | 0.03 | 0.02 | 0.02 | 0.02 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit before tax | 0.14 | 0.37 | 0.04 | 1.36 | 1.03 | -0.28 | -0.98 | 0.04 | 1.30 | -0.24 | 1.13 | 5.26 | 3.89 |
| Tax % | 614.29% | 0.00% | 0.00% | 0.00% | 74.76% | 0.00% | -11.22% | 0.00% | 10.00% | 0.00% | 19.47% | 23.76% | 26.74% |
| Net Profit | -0.72 | 0.36 | 0.04 | 1.37 | 0.26 | -0.28 | -0.87 | 0.04 | 1.17 | -0.24 | 0.90 | 4.01 | 2.85 |
| EPS in Rs | -0.01 | 0.00 | 0.00 | 0.02 | 0.00 | -0.00 | -0.01 | 0.00 | 0.02 | -0.00 | 0.00 | 0.02 | 0.01 |
Last Updated: August 19, 2025, 7:45 pm
Below is a detailed analysis of the quarterly data for Murae Organisor Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
- For Sales, as of Mar 2025, the value is 515.53 Cr.. The value appears strong and on an upward trend. It has increased from 281.05 Cr. (Dec 2024) to 515.53 Cr., marking an increase of 234.48 Cr..
- For Expenses, as of Mar 2025, the value is 511.64 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 275.79 Cr. (Dec 2024) to 511.64 Cr., marking an increase of 235.85 Cr..
- For Operating Profit, as of Mar 2025, the value is 3.89 Cr.. The value appears to be declining and may need further review. It has decreased from 5.26 Cr. (Dec 2024) to 3.89 Cr., marking a decrease of 1.37 Cr..
- For OPM %, as of Mar 2025, the value is 0.75%. The value appears to be declining and may need further review. It has decreased from 1.87% (Dec 2024) to 0.75%, marking a decrease of 1.12%.
- For Other Income, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Dec 2024) which recorded 0.00 Cr..
- For Interest, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Dec 2024) which recorded 0.00 Cr..
- For Depreciation, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Dec 2024) which recorded 0.00 Cr..
- For Profit before tax, as of Mar 2025, the value is 3.89 Cr.. The value appears to be declining and may need further review. It has decreased from 5.26 Cr. (Dec 2024) to 3.89 Cr., marking a decrease of 1.37 Cr..
- For Tax %, as of Mar 2025, the value is 26.74%. The value appears to be increasing, which may not be favorable. It has increased from 23.76% (Dec 2024) to 26.74%, marking an increase of 2.98%.
- For Net Profit, as of Mar 2025, the value is 2.85 Cr.. The value appears to be declining and may need further review. It has decreased from 4.01 Cr. (Dec 2024) to 2.85 Cr., marking a decrease of 1.16 Cr..
- For EPS in Rs, as of Mar 2025, the value is 0.01. The value appears to be declining and may need further review. It has decreased from 0.02 (Dec 2024) to 0.01, marking a decrease of 0.01.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: October 15, 2025, 3:27 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0 | 9 | 19 | 23 | 35 | 51 | 55 | 41 | 21 | 14 | 3 | 855 | 859 |
| Expenses | 0 | 9 | 18 | 23 | 34 | 47 | 54 | 49 | 25 | 13 | 4 | 845 | 847 |
| Operating Profit | 0 | 0 | 1 | 0 | 2 | 3 | 1 | -8 | -4 | 1 | -0 | 10 | 11 |
| OPM % | 2% | 3% | 2% | 4% | 7% | 2% | -19% | -21% | 7% | -15% | 1% | 1% | |
| Other Income | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 9 | 8 | 2 | 1 | 0 | 9 |
| Interest | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit before tax | 0 | 0 | 0 | 0 | 1 | 2 | 2 | 0 | 3 | 3 | 0 | 10 | 20 |
| Tax % | 31% | 44% | 33% | 27% | 27% | 26% | 25% | 28% | 29% | 29% | 25% | ||
| Net Profit | 0 | 0 | 0 | 0 | 1 | 2 | 2 | 0 | 2 | 2 | 0 | 8 | 15 |
| EPS in Rs | 0.07 | 0.11 | 0.23 | 0.42 | 0.02 | 0.00 | 0.02 | 0.02 | 0.00 | 0.04 | 0.07 | ||
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
YoY Net Profit Growth
| Year | 2018-2019 | 2019-2020 | 2020-2021 | 2022-2023 | 2023-2024 |
|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 100.00% | 0.00% | -100.00% | 0.00% | -100.00% |
| Change in YoY Net Profit Growth (%) | 0.00% | -100.00% | -100.00% | 100.00% | -100.00% |
Murae Organisor Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 5 years from 2018-2019 to 2023-2024.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 58% |
| 5 Years: | 73% |
| 3 Years: | 244% |
| TTM: | 44618% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 53% |
| 5 Years: | 33% |
| 3 Years: | 50% |
| TTM: | 15100% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | -22% |
| 3 Years: | -7% |
| 1 Year: | 19% |
| Return on Equity | |
|---|---|
| 10 Years: | 7% |
| 5 Years: | 5% |
| 3 Years: | 5% |
| Last Year: | 6% |
Last Updated: September 5, 2025, 3:21 pm
Balance Sheet
Last Updated: December 10, 2025, 4:13 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 0.01 | 0.01 | 0.11 | 0.11 | 0.31 | 0.31 | 6 | 6 | 12 | 12 | 49 | 186 |
| Reserves | 0 | 1 | 1 | 1 | 5 | 6 | 8 | 8 | 4 | 6 | 6 | 23 |
| Borrowings | 0 | 1 | 2 | 2 | 7 | 10 | 9 | 11 | 9 | 9 | 0 | 213 |
| Other Liabilities | 0 | 3 | 6 | 7 | 7 | 8 | 12 | 2 | 3 | 1 | 64 | 231 |
| Total Liabilities | 0 | 5 | 9 | 11 | 20 | 23 | 36 | 28 | 29 | 29 | 120 | 652 |
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 0 | 0 | 0 |
| CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 3 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 0 | 5 | 9 | 11 | 19 | 23 | 32 | 27 | 28 | 28 | 120 | 652 |
| Total Assets | 0 | 5 | 9 | 11 | 20 | 23 | 36 | 28 | 29 | 29 | 120 | 652 |
Below is a detailed analysis of the balance sheet data for Murae Organisor Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
- For Equity Capital, as of Mar 2025, the value is 186.00 Cr.. The value appears strong and on an upward trend. It has increased from 49.00 Cr. (Mar 2024) to 186.00 Cr., marking an increase of 137.00 Cr..
- For Reserves, as of Mar 2025, the value is 23.00 Cr.. The value appears strong and on an upward trend. It has increased from 6.00 Cr. (Mar 2024) to 23.00 Cr., marking an increase of 17.00 Cr..
- For Borrowings, as of Mar 2025, the value is 213.00 Cr.. The value appears to be increasing, which may not be favorable. However, Borrowings exceed Reserves, which may signal higher financial risk. It has increased from 0.00 Cr. (Mar 2024) to 213.00 Cr., marking an increase of 213.00 Cr..
- For Other Liabilities, as of Mar 2025, the value is 231.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 64.00 Cr. (Mar 2024) to 231.00 Cr., marking an increase of 167.00 Cr..
- For Total Liabilities, as of Mar 2025, the value is 652.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 120.00 Cr. (Mar 2024) to 652.00 Cr., marking an increase of 532.00 Cr..
- For Fixed Assets, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
- For CWIP, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
- For Investments, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
- For Other Assets, as of Mar 2025, the value is 652.00 Cr.. The value appears strong and on an upward trend. It has increased from 120.00 Cr. (Mar 2024) to 652.00 Cr., marking an increase of 532.00 Cr..
- For Total Assets, as of Mar 2025, the value is 652.00 Cr.. The value appears strong and on an upward trend. It has increased from 120.00 Cr. (Mar 2024) to 652.00 Cr., marking an increase of 532.00 Cr..
However, the Borrowings (213.00 Cr.) are higher than the Reserves (23.00 Cr.), which may signal higher financial risk.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 0.00 | -1.00 | -1.00 | -2.00 | -5.00 | -7.00 | -8.00 | -19.00 | -13.00 | -8.00 | 0.00 | -203.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 125 | 87 | 56 | 111 | 78 | 112 | 95 | 261 | 217 | 1,225 | 108 | |
| Inventory Days | 71 | 78 | 108 | 91 | 86 | 97 | 122 | 179 | 392 | 1,439 | 1 | |
| Days Payable | 113 | 107 | 83 | 77 | 54 | 83 | 10 | 18 | -25 | 7 | 85 | |
| Cash Conversion Cycle | 82 | 58 | 82 | 125 | 111 | 126 | 207 | 422 | 635 | 2,657 | 24 | |
| Working Capital Days | 81 | 24 | 34 | 64 | 57 | 79 | 143 | 279 | 472 | 5,034 | 160 | |
| ROCE % | 0% | 22% | 21% | 22% | 25% | 24% | 17% | 4% | 12% | 12% | 1% | 4% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 20 | Mar 19 |
|---|---|---|
| FaceValue | 10.00 | 10.00 |
| Basic EPS (Rs.) | 2.95 | 53.84 |
| Diluted EPS (Rs.) | 2.95 | 53.83 |
| Cash EPS (Rs.) | 3.11 | 55.06 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 23.51 | 192.64 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 23.51 | 192.64 |
| Revenue From Operations / Share (Rs.) | 89.35 | 1642.90 |
| PBDIT / Share (Rs.) | 5.70 | 108.68 |
| PBIT / Share (Rs.) | 5.54 | 107.46 |
| PBT / Share (Rs.) | 3.97 | 73.78 |
| Net Profit / Share (Rs.) | 2.94 | 53.84 |
| NP After MI And SOA / Share (Rs.) | 2.95 | 53.84 |
| PBDIT Margin (%) | 6.37 | 6.61 |
| PBIT Margin (%) | 6.19 | 6.54 |
| PBT Margin (%) | 4.44 | 4.49 |
| Net Profit Margin (%) | 3.29 | 3.27 |
| NP After MI And SOA Margin (%) | 3.30 | 3.27 |
| Return on Networth / Equity (%) | 12.55 | 27.94 |
| Return on Capital Employeed (%) | 21.50 | 38.80 |
| Return On Assets (%) | 4.65 | 7.14 |
| Long Term Debt / Equity (X) | 0.09 | 0.43 |
| Total Debt / Equity (X) | 0.60 | 1.40 |
| Current Ratio (X) | 1.58 | 1.55 |
| Quick Ratio (X) | 0.96 | 0.80 |
| Interest Coverage Ratio (X) | 3.63 | 3.23 |
| Interest Coverage Ratio (Post Tax) (X) | 2.88 | 2.60 |
| Enterprise Value (Cr.) | 37.89 | 0.00 |
| EV / Net Operating Revenue (X) | 0.68 | 0.00 |
| EV / EBITDA (X) | 10.78 | 0.00 |
| MarketCap / Net Operating Revenue (X) | 0.53 | 0.00 |
| Price / BV (X) | 2.02 | 0.00 |
| Price / Net Operating Revenue (X) | 0.53 | 0.00 |
| EarningsYield | 0.06 | 0.00 |
After reviewing the key financial ratios for Murae Organisor Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 20, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 19) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 20, the value is 2.95. This value is below the healthy minimum of 5. It has decreased from 53.84 (Mar 19) to 2.95, marking a decrease of 50.89.
- For Diluted EPS (Rs.), as of Mar 20, the value is 2.95. This value is below the healthy minimum of 5. It has decreased from 53.83 (Mar 19) to 2.95, marking a decrease of 50.88.
- For Cash EPS (Rs.), as of Mar 20, the value is 3.11. This value is within the healthy range. It has decreased from 55.06 (Mar 19) to 3.11, marking a decrease of 51.95.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 20, the value is 23.51. It has decreased from 192.64 (Mar 19) to 23.51, marking a decrease of 169.13.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 20, the value is 23.51. It has decreased from 192.64 (Mar 19) to 23.51, marking a decrease of 169.13.
- For Revenue From Operations / Share (Rs.), as of Mar 20, the value is 89.35. It has decreased from 1,642.90 (Mar 19) to 89.35, marking a decrease of 1,553.55.
- For PBDIT / Share (Rs.), as of Mar 20, the value is 5.70. This value is within the healthy range. It has decreased from 108.68 (Mar 19) to 5.70, marking a decrease of 102.98.
- For PBIT / Share (Rs.), as of Mar 20, the value is 5.54. This value is within the healthy range. It has decreased from 107.46 (Mar 19) to 5.54, marking a decrease of 101.92.
- For PBT / Share (Rs.), as of Mar 20, the value is 3.97. This value is within the healthy range. It has decreased from 73.78 (Mar 19) to 3.97, marking a decrease of 69.81.
- For Net Profit / Share (Rs.), as of Mar 20, the value is 2.94. This value is within the healthy range. It has decreased from 53.84 (Mar 19) to 2.94, marking a decrease of 50.90.
- For NP After MI And SOA / Share (Rs.), as of Mar 20, the value is 2.95. This value is within the healthy range. It has decreased from 53.84 (Mar 19) to 2.95, marking a decrease of 50.89.
- For PBDIT Margin (%), as of Mar 20, the value is 6.37. This value is below the healthy minimum of 10. It has decreased from 6.61 (Mar 19) to 6.37, marking a decrease of 0.24.
- For PBIT Margin (%), as of Mar 20, the value is 6.19. This value is below the healthy minimum of 10. It has decreased from 6.54 (Mar 19) to 6.19, marking a decrease of 0.35.
- For PBT Margin (%), as of Mar 20, the value is 4.44. This value is below the healthy minimum of 10. It has decreased from 4.49 (Mar 19) to 4.44, marking a decrease of 0.05.
- For Net Profit Margin (%), as of Mar 20, the value is 3.29. This value is below the healthy minimum of 5. It has increased from 3.27 (Mar 19) to 3.29, marking an increase of 0.02.
- For NP After MI And SOA Margin (%), as of Mar 20, the value is 3.30. This value is below the healthy minimum of 8. It has increased from 3.27 (Mar 19) to 3.30, marking an increase of 0.03.
- For Return on Networth / Equity (%), as of Mar 20, the value is 12.55. This value is below the healthy minimum of 15. It has decreased from 27.94 (Mar 19) to 12.55, marking a decrease of 15.39.
- For Return on Capital Employeed (%), as of Mar 20, the value is 21.50. This value is within the healthy range. It has decreased from 38.80 (Mar 19) to 21.50, marking a decrease of 17.30.
- For Return On Assets (%), as of Mar 20, the value is 4.65. This value is below the healthy minimum of 5. It has decreased from 7.14 (Mar 19) to 4.65, marking a decrease of 2.49.
- For Long Term Debt / Equity (X), as of Mar 20, the value is 0.09. This value is below the healthy minimum of 0.2. It has decreased from 0.43 (Mar 19) to 0.09, marking a decrease of 0.34.
- For Total Debt / Equity (X), as of Mar 20, the value is 0.60. This value is within the healthy range. It has decreased from 1.40 (Mar 19) to 0.60, marking a decrease of 0.80.
- For Current Ratio (X), as of Mar 20, the value is 1.58. This value is within the healthy range. It has increased from 1.55 (Mar 19) to 1.58, marking an increase of 0.03.
- For Quick Ratio (X), as of Mar 20, the value is 0.96. This value is below the healthy minimum of 1. It has increased from 0.80 (Mar 19) to 0.96, marking an increase of 0.16.
- For Interest Coverage Ratio (X), as of Mar 20, the value is 3.63. This value is within the healthy range. It has increased from 3.23 (Mar 19) to 3.63, marking an increase of 0.40.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 20, the value is 2.88. This value is below the healthy minimum of 3. It has increased from 2.60 (Mar 19) to 2.88, marking an increase of 0.28.
- For Enterprise Value (Cr.), as of Mar 20, the value is 37.89. It has increased from 0.00 (Mar 19) to 37.89, marking an increase of 37.89.
- For EV / Net Operating Revenue (X), as of Mar 20, the value is 0.68. This value is below the healthy minimum of 1. It has increased from 0.00 (Mar 19) to 0.68, marking an increase of 0.68.
- For EV / EBITDA (X), as of Mar 20, the value is 10.78. This value is within the healthy range. It has increased from 0.00 (Mar 19) to 10.78, marking an increase of 10.78.
- For MarketCap / Net Operating Revenue (X), as of Mar 20, the value is 0.53. This value is below the healthy minimum of 1. It has increased from 0.00 (Mar 19) to 0.53, marking an increase of 0.53.
- For Price / BV (X), as of Mar 20, the value is 2.02. This value is within the healthy range. It has increased from 0.00 (Mar 19) to 2.02, marking an increase of 2.02.
- For Price / Net Operating Revenue (X), as of Mar 20, the value is 0.53. This value is below the healthy minimum of 1. It has increased from 0.00 (Mar 19) to 0.53, marking an increase of 0.53.
- For EarningsYield, as of Mar 20, the value is 0.06. This value is below the healthy minimum of 5. It has increased from 0.00 (Mar 19) to 0.06, marking an increase of 0.06.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Murae Organisor Ltd:
- Net Profit Margin: 3.29%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 21.5% (Industry Average ROCE: 16.29%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 12.55% (Industry Average ROE: 15.2%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 2.88
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 0.96
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 3.5 (Industry average Stock P/E: 52.81)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.6
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 3.29%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Pharmaceuticals | A-1311, Sun West Bank, Ashram Road, Ahmedabad Gujarat 380009 | csgauravbachani@gmail.com http://www.earumpharma.com |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Manthan Ramshbhai Tilva | Managing Director |
| Mr. Sanket Ladani | Non Executive Director |
| Mr. Akshay Talshibhai Sanepara | Independent Director |
| Mr. Vinod Rajabhai Bhadarka | Independent Director |
| Ms. Khyati Kanaiyalal Patel | Independent Director |
FAQ
What is the intrinsic value of Murae Organisor Ltd?
Murae Organisor Ltd's intrinsic value (as of 15 December 2025) is 0.17 which is 34.62% lower the current market price of 0.26, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 53.2 Cr. market cap, FY2025-2026 high/low of 1.12/0.25, reserves of ₹23 Cr, and liabilities of 652 Cr.
What is the Market Cap of Murae Organisor Ltd?
The Market Cap of Murae Organisor Ltd is 53.2 Cr..
What is the current Stock Price of Murae Organisor Ltd as on 15 December 2025?
The current stock price of Murae Organisor Ltd as on 15 December 2025 is 0.26.
What is the High / Low of Murae Organisor Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Murae Organisor Ltd stocks is 1.12/0.25.
What is the Stock P/E of Murae Organisor Ltd?
The Stock P/E of Murae Organisor Ltd is 3.50.
What is the Book Value of Murae Organisor Ltd?
The Book Value of Murae Organisor Ltd is 1.02.
What is the Dividend Yield of Murae Organisor Ltd?
The Dividend Yield of Murae Organisor Ltd is 0.00 %.
What is the ROCE of Murae Organisor Ltd?
The ROCE of Murae Organisor Ltd is 4.20 %.
What is the ROE of Murae Organisor Ltd?
The ROE of Murae Organisor Ltd is 5.69 %.
What is the Face Value of Murae Organisor Ltd?
The Face Value of Murae Organisor Ltd is 1.00.